TABLE 2.
Presentation
| Period 1 (N = 139) | Period 2 (N = 95) | P Value | |
| Clinical presentation n (%) | |||
| Critical limb ischemia | 76 (55) | 47 (49) | |
| Neuro-ischemic infection/tissue loss | 37 (27) | 26 (27) | 0.26∗ |
| Diabetic foot infection/tissue loss | 17 (12) | 16 (17) | |
| Acute limb ischaemia | 8 (6) | 4 (4) | |
| Aneurysmal disease | 1 (1) | 2 (2) | |
| Rutherford classification n (%) | N=113 | N=73 | |
| 4 | 30 (27) | 28 (38) | |
| 5 | 41 (36) | 24 (32) | 0.25∗ |
| 6 | 46 (40) | 21 (29) | |
| Level of critical lesion (s) n (%) | |||
| Iliac | 13 (12) | 6 (8) | |
| Femoro-popliteal | 31 (28) | 17 (23) | 0.19∗ |
| Infra-popliteal | 26 (23) | 14 (19) | |
| Multi-level | 43 (38) | 36 (49) | |
| Overall GLASS classification n (%) | |||
| I | 22 (19) | 19 (26) | |
| II | 11 (10) | 9 (12) | 0.38∗ |
| III | 80 (71) | 45 (62) | 0.014‡ |
| WCC on admission - mean (±SD) | 9.5 (±3.9) | 11 (±4.5) | |
| CRP on admission - median (range) | 44 (1–354) | 73 (1–321) | 0.004† |
∗
Chi-square.
†
Man-Whitney U test.
‡
Unpaired t-test.